The impact of osteosarcopenia in patients with unresectable or recurrent biliary tract cancer receiving palliative chemotherapy.
Tsuyoshi TakedaTakeshi OkamotoTakashi SasakiTatsuki HiraiTakahiro IshitsukaManabu YamadaHiroki NakagawaTakafumi MieTakaaki FurukawaAkiyoshi KasugaMasato OzakaNaoki SasahiraPublished in: Japanese journal of clinical oncology (2023)
Osteosarcopenia was associated with poor survival in unresectable or recurrent biliary tract cancer treated with chemotherapy. This study highlights the potential importance of screening for osteosarcopenia in patients with biliary tract cancer.